MARTINI, Maurizio
 Distribuzione geografica
Continente #
EU - Europa 5.672
AS - Asia 4.284
NA - Nord America 4.244
SA - Sud America 1.512
AF - Africa 131
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 15.848
Nazione #
US - Stati Uniti d'America 4.125
RU - Federazione Russa 3.447
SG - Singapore 2.209
BR - Brasile 1.307
CN - Cina 795
IE - Irlanda 551
IT - Italia 549
HK - Hong Kong 542
SE - Svezia 335
VN - Vietnam 228
FR - Francia 181
DE - Germania 165
IN - India 81
PL - Polonia 79
AT - Austria 69
ID - Indonesia 69
GB - Regno Unito 68
AR - Argentina 66
NL - Olanda 63
FI - Finlandia 58
MX - Messico 49
BD - Bangladesh 45
CA - Canada 45
TR - Turchia 43
ZA - Sudafrica 43
IQ - Iraq 38
EC - Ecuador 31
TH - Thailandia 30
VE - Venezuela 30
CO - Colombia 29
UZ - Uzbekistan 27
MA - Marocco 26
UA - Ucraina 24
JP - Giappone 23
PK - Pakistan 19
KE - Kenya 15
PY - Paraguay 15
PE - Perù 14
ES - Italia 13
JO - Giordania 12
AZ - Azerbaigian 11
SA - Arabia Saudita 11
AE - Emirati Arabi Uniti 10
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 9
EG - Egitto 9
KZ - Kazakistan 9
OM - Oman 9
UY - Uruguay 9
AL - Albania 8
KG - Kirghizistan 8
PH - Filippine 8
TN - Tunisia 8
BG - Bulgaria 7
BH - Bahrain 7
CL - Cile 6
RO - Romania 6
RS - Serbia 6
GE - Georgia 5
IL - Israele 5
JM - Giamaica 5
LB - Libano 5
LT - Lituania 5
NP - Nepal 5
SN - Senegal 5
TW - Taiwan 5
AO - Angola 4
BE - Belgio 4
BN - Brunei Darussalam 4
DO - Repubblica Dominicana 4
NO - Norvegia 4
PS - Palestinian Territory 4
BO - Bolivia 3
BY - Bielorussia 3
CH - Svizzera 3
DZ - Algeria 3
GR - Grecia 3
HU - Ungheria 3
MD - Moldavia 3
MY - Malesia 3
PA - Panama 3
PR - Porto Rico 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BB - Barbados 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
LK - Sri Lanka 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
QA - Qatar 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CY - Cipro 1
GY - Guiana 1
Totale 15.836
Città #
Moscow 1.143
Ashburn 1.039
Singapore 756
Dublin 551
Hong Kong 535
Dallas 386
San Jose 331
Nyköping 296
Chandler 257
Princeton 240
Medford 204
Messina 199
Beijing 144
The Dalles 134
Lauterbourg 125
Los Angeles 109
São Paulo 102
Buffalo 74
Warsaw 71
Ho Chi Minh City 63
Guangzhou 61
Jakarta 58
Munich 57
Redondo Beach 53
Santa Clara 49
Frankfurt am Main 48
Hanoi 46
Belo Horizonte 42
Council Bluffs 41
Nuremberg 41
Rio de Janeiro 37
New York 35
Vienna 35
Amsterdam 34
Orem 34
Milan 30
Bangkok 29
Rome 29
Tianjin 28
Brasília 26
Johannesburg 26
Stockholm 26
Tashkent 26
Porto Alegre 25
Shanghai 25
Turku 25
Des Moines 24
Montreal 24
Catania 23
Chennai 23
Tokyo 23
Lappeenranta 22
Brooklyn 20
Atlanta 19
Mexico City 19
Denver 18
London 18
Curitiba 17
Xi'an 17
San Francisco 16
Salvador 15
Shenzhen 15
Campo Grande 14
Manchester 14
Chicago 13
Quito 13
Seattle 13
São José dos Campos 13
Baghdad 12
Dong Ket 12
Nairobi 12
Paris 12
Santo André 12
Amman 11
Ankara 11
Baku 11
Boston 11
Campinas 11
Helsinki 11
Abidjan 10
Fortaleza 10
Guarulhos 10
Lima 10
Mumbai 10
Pelotas 10
Phoenix 10
Sumaré 10
Xiamen 10
Casablanca 9
Caxias do Sul 9
Goiânia 9
Istanbul 9
Joinville 9
Ribeirão Preto 9
Toronto 9
Wilmington 9
Bishkek 8
Boardman 8
Dhaka 8
Duque de Caxias 8
Totale 8.438
Nome #
Overexpression of PRV-1 gene in polycythemia rubra vera and essential thrombocythemia 192
Aggressive variants of follicular cell-derived thyroid carcinoma: an overview 191
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas 177
Mutations of the BIK gene in human peripheral B-cell lymphomas 176
Short communication: proangiogenic hematopoietic cells in acute HIV infection 175
A Risk Score Based on 5 Clinico-Pathological Variables Predicts Recurrence of Atypical Meningiomas 170
A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration 157
Autophagic-Related Proteins in Brain Gliomas: Role, Mechanisms, and Targeting Agents 147
Retzius-sparing vs. standard robot-assisted radical prostatectomy for clinically localised prostate cancer: a comparative study 141
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 135
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors 134
ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism 133
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience. 133
A multi-surgeon learning curve analysis of overall and site-specific positive surgical margins after RARP and implications for training 130
Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas 129
Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives 128
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples 127
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey 126
The Morphology of Nasal Polyps in Different Age Groups: Histopathological Features 120
The Simultaneous Use of Bladder Epicheck® and Urinary Cytology Can Improve the Sensitivity and Specificity of Diagnostic Follow-Up of Urothelial Lesions: Up-to-Date Data from a Multi-Institutional Cohort 119
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 118
Histologic Evaluation of Thyroid Nodules Treated with Thermal Ablation: An Institutional Experience 113
Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysis 112
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: new insights 112
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples 110
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 109
The minefield of indeterminate thyroid nodules: could artificial intelligence be a suitable diagnostic tool? 109
The Role of CD56 in Thyroid Fine Needle Aspiration Cytology: A Pilot Study Performed on Liquid Based Cytology 109
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 106
A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular Insights 106
Morphological features that can predict BRAFV600E -mutated carcinoma in paediatric thyroid cytology 106
Rare histotypes of epithelial biliary tract tumors: A literature review 106
First-line ICIs in renal cell carcinoma 105
ADAR2 Protein Is Associated with Overall Survival in GBM Patients and Its Decrease Triggers the Anchorage-Independent Cell Growth Signature 105
A systematic review and meta-analysis of CK20, CD44, Ki67 and p53 as immunohistochemical markers in bladder carcinoma in situ 103
A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy 102
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group 102
Immunoexpression of autophagy‑related proteins in a single‑center series of sporadic adult conventional clival chordomas 101
null 100
The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF V600E mutation 100
Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation 99
A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants 99
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 98
Pilocytic astrocytoma: The paradigmatic entity in low‑grade gliomas (Review) 98
DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis 97
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 97
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 96
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study) 95
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 95
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 95
34BetaE12 and Alfa-Methylacyl Coenzyme A Racemase (AMACR) Antibodies Better Than p63 Antibody Distinguish Normal and Neoplastic Glands in Prostatic Tissue With Thermal Artifacts 95
The Role of Cytology in the Diagnosis of Subcentimeter Thyroid Lesions 93
Cuproptosis: A Review on Mechanisms, Role in Solid and Hematological Tumors, and Association with Viral Infections 93
Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma 92
PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker 92
The role of fine-needle aspiration in the thyroid nodules of elderly patients 92
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 92
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 90
Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization 89
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 89
Biomarkers of response to advanced prostate cancer therapy 89
Telomerase inhibition in malignant gliomas: a systematic review 89
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 89
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 88
Adult and cord blood endothelial progenitor cells have different gene expression profiles and immunogenic potential 88
Methylation study of the Paris system for reporting urinary (TPS) categories 88
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 87
Morphology combined with ancillary techniques: an algorithm approach for thyroid nodules 87
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer 86
Brain Invasion along Perivascular Spaces by Glioma Cells: Relationship with Blood-Brain Barrier 86
Absence of structural mutations of the BAK gene in B cell lymphomas 86
Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study 85
Aseptic Loosening in Total Hip Arthroplasty: Pathophysiology, Biomarkers, and Preventive Treatment Strategies 84
Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma 83
Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples 82
A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes 82
Molecular testing in EBUS-TBNA specimens of lung adenocarcinoma: a study of concordance between cell block method and liquid-based cytology in appraising sample cellularity and EGFR mutations 82
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 80
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 80
Fusobacterium nucleatum and Gastric Cancer: An Emerging Connection 80
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 80
The cytologic category of oncocytic (Hurthle) cell neoplasm mostly includes low-risk lesions at histology: an institutional experience 80
BRAF (V600E) MUTATION ANALYSIS ON LBC-PROCESSED ASPIRATION BIOPSIES PREDICTS BILATERALITY AND NODAL INVOLVEMENT IN PAPILLARY THYROID MICROCARCINOMA 80
Bleeding "sarcomatosis" as a rare presentation of vascular graft-related angiosarcoma: case report and review of the literature 80
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 79
Is thyroid gland only a "land" for primary malignancies? Role of morphology and immunocytochemistry 79
To obtain more with less: cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 79
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 78
Neuroimages and Neuropathology of a Stroke-Like Cerebral Lymphomatoid Granulomatosis 78
Roles for epigenetic and other biomarkers in upper tract urothelial carcinoma diagnosis and surveillance 78
Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker 77
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study 77
The potential of liquid-based cytology in lymph node cytological evaluation: the role of morphology and the aid of ancillary techniques 76
Targeting the mitogen‑activated protein kinase kinase and protein kinase A pathways overcomes acquired resistance to Selumetinib in low‑grade glioma cells 75
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 75
Endoscopic Ultrasound-Guided Fine-Needle Aspiration With Liquid-Based Cytologic Preparation in the Diagnosis of Primary Pancreatic Lymphoma 75
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 74
How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis 74
Detection of ectopic thyroid remnants: a serious diagnostic dilemma. When molecular biology and immunohistochemistry can solve the problem 74
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models 74
Totale 10.203
Categoria #
all - tutte 55.171
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.171


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 12 0 12
2021/2022533 0 3 0 1 10 3 12 6 2 1 11 484
2022/20231.561 248 111 78 63 50 133 46 66 643 19 26 78
2023/2024693 25 55 24 68 20 27 6 32 168 108 21 139
2024/20254.228 44 34 67 192 252 124 308 676 824 198 636 873
2025/20269.104 357 568 613 573 832 1.935 1.357 1.088 1.248 533 0 0
Totale 16.239